Definitive Healthcare Corp.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kevin D. Coop
- Full Time Employees
- 682
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 492 Old Connecticut Path Framingham MA United States of America 01701
- IPO Date
- Sep 15, 2021
- CIK
- 0001861795
- Website
- definitivehc.com
- Similar Companies
- Business
- Definitive Healthcare Corp. Definitive Healthcare Corp. (DH) provides software-as-a-service (SaaS) healthcare commercial intelligence through a platform that transforms data, analytics, and expertise into actionable insights for biopharma, medtech, healthcare providers, software and IT firms, and professional services; the platform features 16 intelligence modules covering sales intelligence, marketing optimization, clinical research and product development, strategy, talent acquisition, market planning, go-to-market strategies, healthcare provider affiliations, medical claims data, IDN hierarchies, RFP processes, physician prescribing habits, population health data, custom reporting, mapping, and CRM integrations. Founded in 2011 and headquartered in Framingham, Massachusetts, the company operates primarily in the United States with additional locations in Sweden and India, deriving substantially all revenue from subscription fees and support services. Recent developments include a strategic data partnership with a $10 million CapEx investment in 2024, refinancing of debt to a $175 million term loan and $50 million revolving facility extending to 2030, integration of med device sales into the biopharma team, alignment of customer success teams with sales incentives, and investments in AI-powered tools for physician analysis and enterprise customer growth driving raised 2025 revenue and profit guidance.
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
Definitive Healthcare Q2 Earnings Call Highlights
Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform
Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success
Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights
Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights
Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
Definitive Healthcare Reports Financial Results for First Quarter 2026
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast
Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Hold” by Brokerages
Definitive Healthcare Corp. (DH) Matches Q4 Earnings Estimates
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025
Definitive Healthcare (DH) Projected to Post Quarterly Earnings on Thursday